Browse hierarchy: [Clinical Chemistry (CH)](/submissions/CH) → [Subpart B — Clinical Chemistry Test Systems](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems) → [21 CFR 862.1380](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/862.1380) → JMK — Acid, Alpha-Ketobutyric And Nadh (U.V.), Hydroxybutyric Dehydrogenase

# JMK · Acid, Alpha-Ketobutyric And Nadh (U.V.), Hydroxybutyric Dehydrogenase

_Clinical Chemistry · 21 CFR 862.1380 · Class 1_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK

## Overview

- **Product Code:** JMK
- **Device Name:** Acid, Alpha-Ketobutyric And Nadh (U.V.), Hydroxybutyric Dehydrogenase
- **Regulation:** [21 CFR 862.1380](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/862.1380)
- **Device Class:** 1
- **Review Panel:** [Clinical Chemistry](/submissions/CH)

## Identification

A hydroxybutyric dehydrogenase test system is a device intended to measure the activity of the enzyme alpha-hydroxybutric dehydrogenase (HBD) in plasma or serum. HBD measurements are used in the diagnosis and treatment of myocardial infarction, renal damage (such as rejection of transplants), certain hematological diseases (such as acute leukemias and megaloblastic anemias) and, to a lesser degree, liver disease.

## Classification Rationale

Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Recent Cleared Devices (16 of 16)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K983860](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K983860.md) | MTM BIOSCANNER K TEST STRIPS, CAT # BSA610 | Polymer Technology Systems, Inc. | Dec 27, 1999 | SESE |
| [K981865](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K981865.md) | MTM BIOSCANNER K TEST STRIPS | Polymer Technology Systems, Inc. | Feb 26, 1999 | SESE |
| [K953452](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K953452.md) | KETOREX C SANWA | Ihara Medics U.S., Inc. | May 2, 1996 | SESE |
| [K941427](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K941427.md) | SERUM @-HYDROXYBUTYRATE DEHYDROGENASE (HBDH) | Teco Diagnostics | Mar 13, 1995 | SESE |
| [K862319](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K862319.md) | HBDH (OPTIMIZED) REAGENT | Sigma Chemical Co. | Jul 7, 1986 | SESE |
| [K843774](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K843774.md) | RAICHEM X-HBDH REAGENT | Reagents Applications, Inc. | Oct 31, 1984 | SESE |
| [K822739](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K822739.md) | AHBD | Gilford Diagnostics | Oct 18, 1982 | SESE |
| [K821877](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K821877.md) | ULTRAZYME PLUS HBD | Harleco Diagnostics | Jul 14, 1982 | SESE |
| [K781720](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K781720.md) | HBDH ENZYME KINETIC REAGENT SET | Medical Analysis Systems, Inc. | Nov 3, 1978 | SESE |
| [K780104](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K780104.md) | ULTRAZYME PLUS HBD | Harleco | Feb 13, 1978 | SESE |
| [K780073](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K780073.md) | HBDH REAGENT SET | Medical Analysis Systems, Inc. | Feb 13, 1978 | SESE |
| [K780042](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K780042.md) | HYDORRYBUTYRATE DEHYDROGENASE | Beckman Instruments, Inc. | Feb 1, 1978 | SESE |
| [K772033](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K772033.md) | GEMSAEC APPLI. FOR ULTRAZYME PLUS ALP* | Harleco | Nov 17, 1977 | SESE |
| [K771474](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K771474.md) | MULTISTAT III X-HBDH TEST | Instrumentation Laboratory CO | Sep 13, 1977 | SESE |
| [K770871](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K770871.md) | ULTRAZYME PLUS HBD | Harleco | Jul 14, 1977 | SESE |
| [K760023](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK/K760023.md) | ULTRAZYME HBD | Harleco | Aug 26, 1976 | SESE |

## Top Applicants

- Harleco — 4 clearances
- Medical Analysis Systems, Inc. — 2 clearances
- Polymer Technology Systems, Inc. — 2 clearances
- Beckman Instruments, Inc. — 1 clearance
- Gilford Diagnostics — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JMK)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com